Skip to main content

Quantitation of Mdr1 Transcript by PCR a Tool for Monitoring Drug Resistance in Cancer Chemotherapy

  • Chapter
PCR Topics

Abstract

Intrinsic or aquired resistance to cytotoxic drugs is one of the major reasons which limits the effectiveness of the chemotherapy of cancer [1]. Prognosis will improve if adequate diagnostic means are available which allow the detection of drug-resistant cell clones during the initial staging and subsequent treatment of neoplasms. A particular challenge is the management of multidrug-resistance (MDR). In most cases the overexpression of P-glycoprotein (mdr1) is causative responsible for this complex phenotype of cross resistance to anthracyclines, epidophyllotoxins, Vinca alkaloids and of collateral sensitivity to steroids, cyclosporines and certain calcium channel blockers [2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Goldie JH, Coldman AJ (1984) The genetic origin of drug resistance in neoplasms: Implication for systematic therapy. Cancer Research 44:3643–3653

    PubMed  CAS  Google Scholar 

  2. Endicott JA, Ling V (1989) The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 15:137–171

    Article  Google Scholar 

  3. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487–491

    Article  PubMed  CAS  Google Scholar 

  4. Rappolee DA, Mark D, Banda MJ, Werb Z (1988) Wound macrophages express TGF-and other growth factors in vivo: Analysis by mRNA phenotyping. Science 241:706–712

    Google Scholar 

  5. Mennecier F, Daegelen D, Schweighoffer F, Levin M, Kahn A (1986) Expression of aldolase A messenger RNAs in human adult and foeteal tissues and in hepatoma. Biochem Biophys Res Comm 134:1093–1100

    Article  PubMed  CAS  Google Scholar 

  6. Becker-André M, Hahlbrock K (1989) Absolute mRNA quantitation using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY). Nucl Acids Res 17:9437–9446

    Article  PubMed  Google Scholar 

  7. Gilliland G, Perrin S, Blanchard K, Bunn HF (1990) Analysis of cytokine mRNA and DNA: Detection and quantitation by competitive polymerase chain reaction. Proc Natl Acad Sci USA 87:2725–2729

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hoof, T., Riordan, J.R., Tümmler, B. (1991). Quantitation of Mdr1 Transcript by PCR a Tool for Monitoring Drug Resistance in Cancer Chemotherapy. In: Rolfs, A., Schumacher, H.C., Marx, P. (eds) PCR Topics. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75924-6_39

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-75924-6_39

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-52934-7

  • Online ISBN: 978-3-642-75924-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics